137 results
Page 3 of 7
6-K
EX-99
21e2vm3i85kcxjeoi7x
3 Jun 20
Current report (foreign)
8:30am
424B5
2vpo 750zd2g29e8cfef
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
3hz0db4110cjp1702e2a
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
pbh0qe optgm
28 Jun 19
BioLineRx Announces Change in Ratio of American
4:01pm
20-F/A
bq1xjqf
5 Jun 19
Annual report (foreign) (amended)
7:00am
6-K
EX-99
h6o0gryb0al8d
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
5rfpcsx
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
0v4vy2b0dp7q nq
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99.2
39ssd8qlvl wa6og0a
4 Feb 19
Current report (foreign)
4:30pm
6-K
xfg3 o2vx8bfimvc64r
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-10.3
mm63 8pa6bfq
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am